Skip to main content
Premium Trial:

Request an Annual Quote

Inova Taps Avere Infrastructure to Move Data

Premium

NEW YORK (GenomeWeb) – Avere said this week that the Inova Translation Medicine Institute (ITMI) will use Avere infrastructure to move genomic sequence data between its local storage and Amazon S3 infrastructure.

Specifically, ITMI — Inova Health System's research and development arm — will use Avere's FXT Series Edge Filers with FlashMove software to move data stored in its internally developed database. The database contains 5000 whole genome sequences and ITMI plans to add 20,000 whole genomes over the next two years. It will use this data to study diseases such as cancer, heart diseases, stroke, and diabetes.

"Avere's approach and vision for hybrid cloud storage aligns perfectly with our integrated environment," Greg Eley, CTO at Inova Translational Medicine Institute, said in a statement. "We see their solutions as the glue that allows us to tie together disparate systems and treat the cloud as an on-premise data center, without the maintenance overhead."

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.